InsidersTradesSigma
Follow the Prostatype Genomics AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Prostatype Genomics AB has logged 6 public disclosures. Market capitalisation: €15.2m. The latest transaction was filed on 10 September 2026 (Purchase). Among the most active insiders: Anders Liljeblad. All data is free.
6
Insider Decl.
n/a
Thresholds
€53,863
4 ops.
Buy Volume
€152
1 ops.
Sell Volume
46Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 September 2026
Declarations6 total
500,000 shares@ SEK 0.056OptionISIN SE0029529783FI:csv-a4525078569cf2c20a2f
715,000 shares@ SEK 0.100.47% mcap97.7% of flowTeckningsoptionISIN SE0014684569FI:csv-6a8be47796db5500086b
24,248 shares@ SEK 0.070.011% mcap100.0% of flowAktieISIN SE0014684569FI:csv-2968c8e1feb996b5c2d8
1,437,500 shares0TeckningsoptionISIN SE0029529767FI:csv-4d1e1875c74cc399188b
5,750,000 shares@ SEK 0.103.77% mcap100.0% of flowAktieISIN SE0023261532FI:csv-78ed7f85ce46a6e56bfe
2,875,000 shares0TeckningsoptionISIN SE0029529783FI:csv-735015975c41aeefc715
6 of 6 declarations
关于 Prostatype Genomics AB
Prostatype Genomics AB 是一家专注于开发前列腺癌基因组检测的公司。该公司在斯德哥尔摩证券交易所上市。